4-HO-MPMI

A rare tryptamine derivative first synthesised by David Nichols. This drug, also known as lucigenol, has rarely been documented outside the lab. It is known to be a psychedelic similar to other psychoactive tryptamines, with a potency similar to DOI, but little else is known.

Also known as: Lucigenol

Classification

Chemical: Tryptamine
Psychoactive: Psychedelic
Tag: Research-Chemical
Tag: Tentative

Effects

Mentalphysical Stimulation
Decreased Appetite
Pupil Dilation
Restlessness
Sweatingchills
Muscle Tension
Euphoria
Empathy
Insight
Change In Perception
Ego Softening
Confusion
Brightened Color
Closedopen Eye Visuals
Enhanced Tactile Sensation
Visual Distortion
Color Enhancement

Routes of Administration

Oral

Dosage

Common: 1-2 mg
Light: 750-1000 ug
Threshold: 500-750 ug

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

tripsit.me

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu